Lindsay T Fourman1, Pouneh K Fazeli. 1. Department of Medicine (L.T.F., P.K.F.) and Neuroendocrine Unit (P.K.F.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Abstract
CONTEXT: Secondary amenorrhea--the absence of menses for three consecutive cycles--affects approximately 3-4% of reproductive age women, and infertility--the failure to conceive after 12 months of regular intercourse--affects approximately 6-10%. Neuroendocrine causes of amenorrhea and infertility, including functional hypothalamic amenorrhea and hyperprolactinemia, constitute a majority of these cases. OBJECTIVE: In this review, we discuss the physiologic, pathologic, and iatrogenic causes of amenorrhea and infertility arising from perturbations in the hypothalamic-pituitary-adrenal axis, including potential genetic causes. We focus extensively on the hormonal mechanisms involved in disrupting the hypothalamic-pituitary-ovarian axis. CONCLUSIONS: A thorough understanding of the neuroendocrine causes of amenorrhea and infertility is critical for properly assessing patients presenting with these complaints. Prompt evaluation and treatment are essential to prevent loss of bone mass due to hypoestrogenemia and/or to achieve the time-sensitive treatment goal of conception.
CONTEXT: Secondary amenorrhea--the absence of menses for three consecutive cycles--affects approximately 3-4% of reproductive age women, and infertility--the failure to conceive after 12 months of regular intercourse--affects approximately 6-10%. Neuroendocrine causes of amenorrhea and infertility, including functional hypothalamic amenorrhea and hyperprolactinemia, constitute a majority of these cases. OBJECTIVE: In this review, we discuss the physiologic, pathologic, and iatrogenic causes of amenorrhea and infertility arising from perturbations in the hypothalamic-pituitary-adrenal axis, including potential genetic causes. We focus extensively on the hormonal mechanisms involved in disrupting the hypothalamic-pituitary-ovarian axis. CONCLUSIONS: A thorough understanding of the neuroendocrine causes of amenorrhea and infertility is critical for properly assessing patients presenting with these complaints. Prompt evaluation and treatment are essential to prevent loss of bone mass due to hypoestrogenemia and/or to achieve the time-sensitive treatment goal of conception.
Authors: W Wu; J D Cogan; R W Pfäffle; J S Dasen; H Frisch; S M O'Connell; S E Flynn; M R Brown; P E Mullis; J S Parks; J A Phillips; M G Rosenfeld Journal: Nat Genet Date: 1998-02 Impact factor: 38.330
Authors: K K Miller; M S Parulekar; E Schoenfeld; E Anderson; J Hubbard; A Klibanski; S K Grinspoon Journal: J Clin Endocrinol Metab Date: 1998-07 Impact factor: 5.958
Authors: K Clément; C Vaisse; N Lahlou; S Cabrol; V Pelloux; D Cassuto; M Gourmelen; C Dina; J Chambaz; J M Lacorte; A Basdevant; P Bougnères; Y Lebouc; P Froguel; B Guy-Grand Journal: Nature Date: 1998-03-26 Impact factor: 49.962
Authors: Michael J Kreisman; Richard B McCosh; Katherine Tian; Christopher I Song; Kellie M Breen Journal: Neuroendocrinology Date: 2019-08-29 Impact factor: 4.914
Authors: Kimbell L Hetzler; Justin P Hardee; Holly A LaVoie; E Angela Murphy; James A Carson Journal: Am J Physiol Endocrinol Metab Date: 2017-03-14 Impact factor: 4.310
Authors: Satu Kuokkanen; Alex J Polotsky; Justin Chosich; Andrew P Bradford; Anna Jasinska; Tzu Phang; Nanette Santoro; Susan E Appt Journal: Syst Biol Reprod Med Date: 2016-05-17 Impact factor: 3.061
Authors: Jennifer A Yang; Christopher I Song; Jessica K Hughes; Michael J Kreisman; Ruby A Parra; Daniel J Haisenleder; Alexander S Kauffman; Kellie M Breen Journal: Endocrinology Date: 2017-11-01 Impact factor: 4.736
Authors: Meredith L Snook; Luke C Henry; Joseph S Sanfilippo; Anthony J Zeleznik; Anthony P Kontos Journal: JAMA Pediatr Date: 2017-09-01 Impact factor: 16.193
Authors: Nicole C Aurigemma; Kristen J Koltun; Hannah VanEvery; Connie J Rogers; Mary Jane De Souza Journal: Curr Osteoporos Rep Date: 2018-02 Impact factor: 5.096